TB molecular surveillance status report, focussing on rifampicin and multidrug resistance in the EU/EEA

The European Centre for Disease Prevention and Control (ECDC) released a report providing an overview of the dynamics and geographical distribution of rifampicin-resistant (RR)- and multidrug-resistant (MDR) Mycobacterium tuberculosis strains in the European Union/European Economic Area (EU/EEA), focussing on the strains isolated in 2020−2022, and comparing this with whole genome sequencing data collected in 2017−2019 as a part of an EU/EEA pilot project on TB molecular surveillance.